Er Therapeutics Stock Widgets and Gadgets
PNGM Stock | USD 0.0001 0.00 0.00% |
Intraday Equity Chart Quick Equity Feed Equity Search Quote Ticker Widgets Data Sheet |
Live Stock Ticker Example
- PNGM Er Therapeutics
- Latest Piedmont Lithium accelerates executive bonuses
- PNGM 0.0 0.0
- Low 1.0E-4
- High 1.0E-4
- Return On Asset -0.95
- Current Valuation 122.36 K
- Shares Outstanding 58.26 M
- Price To Earning (0.06) X
- Price To Book 143,650 X
- Net Income (426.95 K)
- Cash And Equivalents 650
- Total Debt 48.49 K
- Current Ratio 0.01 X
- Book Value Per Share (0) X
- Cash Flow From Operations (161.43 K)
- Beta 10.4
- Market Capitalization 332.11 K
- Total Asset 423.6 K
- Working Capital (638 K)
- Current Asset 7 K
- Current Liabilities 645 K
- Net Asset 423.6 K
- Rate Of Daily Change 1.0
- Day Median Price 1.0E-4
- Day Typical Price 1.0E-4
Market Snapshot Widget Example
DAX Index Germany | 19,849 0.18 | |
Taiwan Weighted Taiwan | 23,120 0.07 | |
PSI 20 Stock Portugal | 6,326 0.32 | |
CROBEX Croatia | 3,204 0.17 | |
Budapest SE Hungary | 79,493 0.95 | |
IDX 30 Jakarta Indonesia | 424.36 0.55 | |
ISEQ 20 Price Ireland | 1,631 0.42 | |
NYSE Comp USA | 19,341 0.70 | |
Tel Aviv 35 Israel | 2,403 0.61 | |
Coreshares Index Tracker South Afric | 1,128 1.26 | |
IPC MEXICO Mexico | 49,317 0.59 | |
KL Technology Malaysia | 64.10 0.12 | |
IBEX 35 Index Spain | 11,474 0.33 | |
SP Merval Argentina | 1,000,000 0.00 | |
Austrian Traded Index Austria | 3,607 0.50 | |
SPASX Dividend Opportunities Australia | 1,660 0.16 | |
HNX 30 Vietnam | 482.72 0.42 | |
Bucharest BET-NG Romania | 1,214 0.52 | |
AMS Small Cap Netherlands | 1,248 0.89 | |
Oslo Exchange Mutual Norway | 1,367 0.54 | |
BEL Small Belgium | 8,217 1.09 | |
Basic Materials Brazil | 5,571 0.52 | |
Swiss Leader Price Switzerland | 1,900 0.84 | |
Fondo Mutuo ETF Chile | 1,388 0.27 | |
Athens General Comp Greece | 1,449 0.25 | |
Stock Exchange Of Thailand | 1,395 0.56 | |
PX Prague Stock Czech Repub | 1,762 0.41 | |
THE PHILIPPINE STOCK Philippines | 6,535 2.01 | |
WIG 30 Poland | 2,814 0.13 | |
BIST Electricity Turkey | 498.04 0.21 |
Investing Ideas
In addition to having Er Therapeutics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Thematic Opportunities
Explore Investment Opportunities
Compare Er Therapeutics
Compare Er Therapeutics To Peers
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Er Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. To learn how to invest in PNGM Stock, please use our How to Invest in Er Therapeutics guide.You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Is Diversified Metals & Mining space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Er Therapeutics. If investors know PNGM will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Er Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Return On Assets (0.95) |
The market value of Er Therapeutics is measured differently than its book value, which is the value of PNGM that is recorded on the company's balance sheet. Investors also form their own opinion of Er Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Er Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Er Therapeutics' market value can be influenced by many factors that don't directly affect Er Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Er Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Er Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Er Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.